13th Annual T-Cell Lymphoma Forum

JULY 8, 2021 – JULY 10, 2021

Back to Event Homepage


Thank you for your interest in submitting an abstract for the 13th Annual T-Cell Lymphoma Forum. We invite all registered meeting attendees to submit abstracts for poster presentation on their latest research in T-Cell Lymphoma. A list of abstracts will be selected as pre-recorded oral presentations during the conference.

The 13th Annual T-Cell Lymphoma Forum abstract website will open on  and close on . When the site is opened, you will have the opportunity to CREATE AN ACCOUNT and get started on your submission(s). Abstract submission guidelines are listed below for your reference. If you have any questions, please do not hesitate to contact Tristan Nelsen at tnelsen@medscapelive.com.

Abstract Submission Period:  - 

Submission Notification Date: Wednesday, July 7, 2021

We look forward to receiving your abstract submission!

Abstract Submission Guidelines

  • Language: English

  • Authors: full last name, first name, affiliations, degrees and contact information (Note: only the first 6 authors will appear, over 6 will be et al)

  • Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)

  • Maximum of 2 relevant tables or figures: must be 600 dpi .jpg

  • References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)

  • Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)

  • Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions

  • Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.